Shandong Jincheng Pharmaceutical Group Co., Ltd.
|
Shandong Jincheng Pharmaceutical Group Co., Ltd. (Hereafter named as”JINCHENG PHARM”, Stock code: 300233) was established in 2004 and successful launched in Shenzhen GEM Board on June, 2011. The company is honored as National High-New Technology Enterprise. It has three whole owned subsidiary companies—Shandong Jincheng Kerui Chemical Co.,Ltd., Shandong Huihai Pharmaceutical and Chemical Co.,Ltd. ,Shandong Jincheng Zhonghua Bio-Pharmaceutical Co.,Ltd. and four production bases.The company is dedicated to research and development, production and sales for III、IV Cephalosporin intermediates. In this field, the company has great advantage and established Post-Doctoral Scientific Research station and Enterprise Technical Center of Shandong Province. The company is one of the main suppliers who own obvious competitive advantage for cephalosporin intermediates in the world market. Moreover, the company has formed the High-New technical products chain from basic chemicals to pharmaceutical intermediates and extend to special APIs and biopharmaceuticals through actively practices the development pattern of “Change the development mode, Adjust the structure”, improve the independent innovation ability and adjusts and optimize the industrial structure.
|